237 related articles for article (PubMed ID: 27882815)
1. Approaches to developing fast release pellets via wet extrusion-spheronization.
Xia Y; Shi CY; Fang JG; Wang WQ
Pharm Dev Technol; 2018 Jun; 23(5):432-441. PubMed ID: 27882815
[TBL] [Abstract][Full Text] [Related]
2. Use of crospovidone as pelletization aid as alternative to microcrystalline cellulose: effects on pellet properties.
Verheyen P; Steffens KJ; Kleinebudde P
Drug Dev Ind Pharm; 2009 Nov; 35(11):1325-32. PubMed ID: 19832632
[TBL] [Abstract][Full Text] [Related]
3. Influence of MCC II fraction and storage conditions on pellet properties.
Krueger C; Thommes M; Kleinebudde P
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1039-45. PubMed ID: 23872176
[TBL] [Abstract][Full Text] [Related]
4. Production of pellets via extrusion-spheronisation without the incorporation of microcrystalline cellulose: a critical review.
Dukić-Ott A; Thommes M; Remon JP; Kleinebudde P; Vervaet C
Eur J Pharm Biopharm; 2009 Jan; 71(1):38-46. PubMed ID: 18771727
[TBL] [Abstract][Full Text] [Related]
5. Control of drug release by incorporation of sorbitol or mannitol in microcrystalline-cellulose-based pellets prepared by extrusion-spheronization.
Goyanes A; Souto C; Martínez-Pacheco R
Pharm Dev Technol; 2010 Dec; 15(6):626-35. PubMed ID: 20148708
[TBL] [Abstract][Full Text] [Related]
6. Controlled drug release from pellets containing water-insoluble drugs dissolved in a self-emulsifying system.
Serratoni M; Newton M; Booth S; Clarke A
Eur J Pharm Biopharm; 2007 Jan; 65(1):94-8. PubMed ID: 17056237
[TBL] [Abstract][Full Text] [Related]
7. Use of kappa-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. II. Influence of drug and filler type.
Thommes M; Kleinebudde P
Eur J Pharm Biopharm; 2006 May; 63(1):68-75. PubMed ID: 16325384
[TBL] [Abstract][Full Text] [Related]
8. The influence of liquid binder on the liquid mobility and preparation of spherical granules by the process of extrusion/spheronization.
Boutell S; Newton JM; Bloor JR; Hayes G
Int J Pharm; 2002 May; 238(1-2):61-76. PubMed ID: 11996811
[TBL] [Abstract][Full Text] [Related]
9. Use of extrusion aids for successful production of Kollidon
Loka NC; Saripella KK; Pinto CA; Neau SH
Drug Dev Ind Pharm; 2018 Apr; 44(4):632-642. PubMed ID: 29183166
[TBL] [Abstract][Full Text] [Related]
10. Synergistic effect of polyethylene glycol and superdisintegrant on dissolution rate enhancement of simvastatin in pellet formulation.
Afrasiabi Garekani H; Aftabi SF; Nia FF; Javidi M; Nokhodchi A; Sadeghi F
Pharm Dev Technol; 2019 Jul; 24(6):720-728. PubMed ID: 30776937
[TBL] [Abstract][Full Text] [Related]
11. Use of kappa-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. I. Influence of type and fraction of filler.
Thommes M; Kleinebudde P
Eur J Pharm Biopharm; 2006 May; 63(1):59-67. PubMed ID: 16326085
[TBL] [Abstract][Full Text] [Related]
12. A study of the effects of the physical characteristics of microcrystalline cellulose on performance in extrusion spheronization.
Heng PW; Koo OM
Pharm Res; 2001 Apr; 18(4):480-7. PubMed ID: 11451035
[TBL] [Abstract][Full Text] [Related]
13. Alternative extrusion-spheronization aids.
Jain SP; Singh PP; Amin PD
Drug Dev Ind Pharm; 2010 Nov; 36(11):1364-76. PubMed ID: 20521907
[TBL] [Abstract][Full Text] [Related]
14. Co-processed MCC-Eudragit® E excipients for extrusion-spheronization.
Goyanes A; Souto C; Martínez-Pacheco R
Eur J Pharm Biopharm; 2011 Nov; 79(3):658-63. PubMed ID: 21827853
[TBL] [Abstract][Full Text] [Related]
15. Preparation of lovastatin matrix sustained-release pellets by extrusion-spheronization combined with microcrystal dispersion technique.
He H; Shi B; Cai C; Tang X
Arch Pharm Res; 2011 Nov; 34(11):1931-8. PubMed ID: 22139692
[TBL] [Abstract][Full Text] [Related]
16. Effect of microcrystalline cellulose grade and process variables on pellets prepared by extrusion-spheronization.
Alvarez L; Concheiro A; Gómez-Amoza JL; Souto C; Martínez-Pacheco R
Drug Dev Ind Pharm; 2002 Apr; 28(4):451-6. PubMed ID: 12056538
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of microcrystalline cellulose II (MCCII) as an alternative extrusion-spheronization aid.
Rojas J; Kumar V
Pharmazie; 2012 Jul; 67(7):595-7. PubMed ID: 22888514
[TBL] [Abstract][Full Text] [Related]
18. Use of the direct compression aid Ludiflash(®) for the preparation of pellets via wet extrusion/spheronization.
Roblegg E; Schrank S; Griesbacher M; Radl S; Zimmer A; Khinast J
Drug Dev Ind Pharm; 2011 Oct; 37(10):1231-43. PubMed ID: 21438702
[TBL] [Abstract][Full Text] [Related]
19. New co-processed MCC-based excipient for fast release of low solubility drugs from pellets prepared by extrusion-spheronization.
Goyanes A; Martínez-Pacheco R
Drug Dev Ind Pharm; 2015 Mar; 41(3):362-8. PubMed ID: 24279425
[TBL] [Abstract][Full Text] [Related]
20. The influence of non-ionic surfactants on the rheological properties of drug/microcrystalline cellulose/water mixtures and their use in the preparation and drug release performance of pellets prepared by extrusion/spheronization.
Podczeck F; Maghetti A; Newton JM
Eur J Pharm Sci; 2009 Jun; 37(3-4):334-40. PubMed ID: 19491024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
